Cat. No. | Product name | CAS No. |
DC11620 |
RIPK2-IN-8
A potent, selective, orally available RIPK2 inhibitor with IC50 of 3 nM. |
2141969-56-2 |
DC10787 |
GSK2982772
Featured
GSK2982772 is a potent and ATP competitive RIP1 inhibitor with an IC50 of 16 nM. |
1622848-92-3 |
DC9721 |
GSK2983559 active metabolite
Featured
GSK2983559 active metabolite is an active metabolite of GSK2983559. GSK2983559 active metabolite is a receptor interacting protein-2 (RIP2) kinase inhibitor extracted from patent WO/2014043446 A1, compound example 1. |
1423186-80-4 |
DC9733 |
GSK583
Featured
GSK583 is a Highly Potent and Selective Inhibitor of RIP2 Kinase (RIP2K bing IC50=5 nM; rat in vivo PD IC50 = 50 nM). |
1346547-00-9 |
DC10471 |
GSK-872
Featured
GSK-872 is a potent and selective RIPK3 (receptor-interacting protein kinase-3) inhibitor. |
1346546-69-7 |
DC12045 |
HS-1371
Featured
HS-1371 is a novel kinase inhibitor of RIP3-mediated necroptosis. |
2158197-70-5 |
DC10389 |
RIPA-56
Featured
RIPA-56 is a highly potent, selective, and metabolically stable inhibitor of receptor-interacting protein 1 (RIP1) with an IC50 of 13 nM. |
1956370-21-0 |
DC10373 |
WEHI-345
Featured
WEHI-345 is a potent and selective inhibitor of RIPK2, with IC50 of 0.13 μM. |
1354825-58-3 |
DC28704 |
RIP2 kinase inhibitor 1
RIP2 kinase inhibitor 1 (compound 11) is a potent and selective receptor interacting protein 2 (RIP2) kinase inhibitor with an IC50 of 0.03 μM for RIP2 FP. RIP2 kinase inhibitor 1 is used for autoinflammatory disorders. |
2380028-10-2 |
DC40776 |
Necroptosis-IN-1
Necroptosis-IN-1, an analog of Necrostatin-1 (HY-15760), is a potent necroptosi inhibitor. Necroptosis-IN-1 is a RIPK inhibitor. |
1391980-92-9 |